We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+22.01%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$19.1B
AUM Growth
+$2.74B
Cap. Flow
-$133M
Cap. Flow %
-0.7%
Top 10 Hldgs %
36.58%
Holding
315
New
39
Increased
84
Reduced
103
Closed
37

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$270M
2
PANW icon
Palo Alto Networks
PANW
+$111M
3
SNOW icon
Snowflake
SNOW
+$104M
4
RMBS icon
Rambus
RMBS
+$103M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.5M

Sector Composition

Rank Sector Weight
1 Technology 39.81%
2 Healthcare 20.96%
3 Financials 13.96%
4 Industrials 10.11%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
26
Regeneron Pharmaceuticals
REGN
$81.7B
$170M 0.89%
176,958
-20,889
-11% -$19.9M
KLAC icon
27
KLA
KLAC
$221B
$168M 0.88%
2,402,260
+42,930
+2% +$2.76M
WRB icon
28
W.R. Berkley
WRB
$26.3B
$167M 0.88%
2,831,250
-30,000
-1% -$1.62M
SNPS icon
29
Synopsys
SNPS
$73.1B
$159M 0.84%
278,632
+15,051
+6% +$8.28M
ISRG icon
30
Intuitive Surgical
ISRG
$134B
$147M 0.77%
368,951
+50,188
+16% +$19M
ESNT icon
31
Essent Group
ESNT
$6.18B
$139M 0.73%
2,330,500
-57,000
-2% -$3.1M
EG icon
32
Everest Group
EG
$14.6B
$132M 0.69%
330,978
+40,000
+14% +$15M
CLDX icon
33
Celldex Therapeutics
CLDX
$3.08B
$128M 0.67%
3,059,492
-76,379
-2% -$3.14M
PGR icon
34
Progressive
PGR
$128B
$125M 0.66%
604,844
+17,344
+3% +$3.22M
SHOP icon
35
Shopify
SHOP
$172B
$124M 0.65%
1,602,816
-400,906
-20% -$31.7M
MKL icon
36
Markel Group
MKL
$22.3B
$121M 0.63%
79,500
-5,500
-6% -$8.06M
TRV icon
37
Travelers Companies
TRV
$78.9B
$115M 0.6%
500,548
-45,965
-8% -$9.82M
SPOT icon
38
Spotify
SPOT
$114B
$115M 0.6%
435,970
+315,451
+262% +$74.1M
AVDL
39
DELISTED
Avadel Pharmaceuticals
AVDL
$114M 0.6%
6,753,672
+1,890
+0% +$28.1K
MELI icon
40
Mercado Libre
MELI
$96.3B
$113M 0.59%
74,949
+43,406
+138% +$71M
CYTK icon
41
Cytokinetics
CYTK
$10.1B
$113M 0.59%
1,605,576
+188,522
+13% +$14.6M
XENE icon
42
Xenon Pharmaceuticals
XENE
$5.64B
$112M 0.59%
2,612,108
-454,520
-15% -$20.9M
CRM icon
43
Salesforce
CRM
$214B
$110M 0.58%
364,857
+90,444
+33% +$26.1M
AMAT icon
44
Applied Materials
AMAT
$337B
$107M 0.56%
+519,332
New +$95.3M
NBIX icon
45
Neurocrine Biosciences
NBIX
$16B
$107M 0.56%
775,556
-60,277
-7% -$8.23M
AMGN icon
46
Amgen
AMGN
$206B
$105M 0.55%
369,346
+124,354
+51% +$36.4M
ESTC icon
47
Elastic
ESTC
$8.94B
$93M 0.49%
927,809
+61,589
+7% +$7.1M
FROG icon
48
JFrog
FROG
$11.5B
$92.5M 0.49%
2,091,820
+1,530,904
+273% +$59.3M
LLY icon
49
Eli Lilly
LLY
$1.01T
$92.1M 0.48%
118,443
+7,902
+7% +$5.62M
ARM icon
50
Arm
ARM
$255B
$91.4M 0.48%
+731,026
New +$77.5M

Similar funds

Polar Capital Holdings's Q1 2024 Portfolio in Review

As of Q1 2024, Polar Capital Holdings held 315 positions worth $19.1B, up 17% from $16.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Polar Capital Holdings's Q1 2024 filing shows 39 new, 84 increased, 103 reduced and 37 closed positions. Its largest new stake was Applied Materials: 519,332 shares worth $107M. The largest sale was Apple, an estimated $270M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital Holdings's largest Q1 2024 buy was Applied Materials: 519,332 shares worth $107M.
  • Polar Capital Holdings added most to Meta Platforms (Facebook) in Q1 2024, an estimated $214M increase.
  • Polar Capital Holdings's biggest Q1 2024 reduction was Apple, cutting an estimated $270M.
  • Polar Capital Holdings fully exited Rambus in Q1 2024, selling an estimated $103M.
  • Polar Capital Holdings's ten largest holdings make up 37% of its $19.1B portfolio in Q1 2024.
  • Polar Capital Holdings opened 39 new positions and closed 37 in Q1 2024.
  • Polar Capital Holdings's portfolio value rose 17% quarter-over-quarter to $19.1B.

Based on Polar Capital Holdings's 13F filing for Q1 2024, filed 15 May 2024.